ENROFLOXACIN KRKA 100 MG/ML ORAL SOLUTION FOR CHICKENS AND TURKEYS
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
26-05-2015
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
ENROFLOXACIN
Inapatikana kutoka:
Krka, d.d., Novo mesto
ATC kanuni:
QJ01MA90
INN (Jina la Kimataifa):
ENROFLOXACIN
Kipimo:
100 Mg/Ml
Dawa fomu:
Infus/Pdr/Oral Soln
Dawa ya aina:
POM
Kundi la matibabu:
Fowl - Chicken, Fowl - Turkey
Eneo la matibabu:
Enrofloxacin
Matibabu dalili:
Antibacterial
Idhini hali ya:
Authorised
Idhini ya tarehe:
2013-06-14
Tabia za bidhaa
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Enrofloxacin Krka 100 mg/ml oral solution for chickens and turkeys.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml of oral solution contains:
ACTIVE SUBSTANCE:
Enrofloxacin 100 mg
EXCIPIENTS:
Benzyl alcohol 14 mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral solution.
Clear, yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chicken and Turkey.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by the following bacteria susceptible to enrofloxacin:
Chickens
_Mycoplasma gallisepticum,_
_Mycoplasma synoviae,_
_Avibacterium paragallinarum,_
_Pasteurella multocida,_
_Escherichia coli._
Turkey
_Mycoplasma gallisepticum,_
_Mycoplasma synoviae,_
_Pasteurella multocida,_
_Escherichia coli._
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 11/05/2015_
_CRN 7020381_
_page number: 1_
4.3 CONTRAINDICATIONS
Do not use for prophylaxis.
Do not use when resistance / cross-resistance to (fluoro)quinolones is known to occur in the flock intended for
treatment.
Do not use in case of hypersensitivity to the active substance, other (fluoro)quinolones or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Treatment of _Mycoplasma _spp. infections may not eradicate the organism.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones
should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond
poorly, to other classes of antimicrobials.
Whenever possible, fluoroquinoones should only be u
Soma hati kamili
